Xeris Biopharma Holdings Inc Sustainability Reports
Xeris Biopharma Holdings Inc. specializes in developing and commercializing novel formulations of ready-to-use injectable and infusible drug products.
Sector: Health Care
Country: United States
Exchange: Nasdaq Stock Market
ISIN: US98422E1038
4 reports from 2018 to 2022
Company Profile
Xeris Biopharma Holdings Inc
Xeris Biopharma Holdings Inc. specializes in developing and commercializing novel formulations of ready-to-use injectable and infusible drug products.
Reports